Research Institute

Found 2,397 articles

• Shanghai Institute of Materia Medica: Glucagon Receptor Structure Offers New Opportunities for Type 2 Diabetes Drug Discovery

  1/4/2018

  Recently, scientists at SIMM determined the crystal structure of GCGR in complex with a glucagon analogue and partial agonist NNC1702.

• Indiana Biosciences Research Institute Names Lilly Executive Jay McGill COO

  1/3/2018

  McGill brings vast experience in collaboration, partnership, research operations and ventures to the IBRI.

• Dr. Marcus Schabacker Named ECRI Institute's New CEO and President

  12/27/2017

  ECRI Institute's Board of Trustees announces the appointment of Marcus Schabacker, MD, PhD, as the new Chief Executive Officer and President.

• CancerVX, an OncoEpigenetic DNA Immuno Therapy From World Cancer Institute Targets Female Hormonal Cancers, 5 Other Solid Tumor and 4 Hematological Malignancies and May Become the First Bioactive Personalized Universal Cancer Vaccine

  12/22/2017

  World Cancer Institute Inc., today announced the evolutionary platform of cancer clinical protocols originating initially in 2008 /2009 based on molecular cancer genetics and DNA programmable pharmaceutics to inhibit the growth, replication and proliferation of human cancer cells.

• Roswell Park Research Identifies Cells that May be Responsible for Prostate Cancer Recurrence

  12/22/2017

  Although men with prostate cancer usually respond to standard treatment with hormone therapy or chemotherapy, many will eventually experience progression or recurrence despite treatment - particularly those with high-risk or aggressive forms of the disease.

• The Michael J. Fox Foundation Release: Protein Levels in Spinal Fluid Correlate to Posture and Gait Difficulty in Parkinson's Disease

  12/19/2017

  This analysis points to associations that could inform subject selection for clinical trials, speeding testing of symptomatic and disease-modifying therapies.

• Feinstein Institute Grant Funds Fertility Decision Tool for Women Cancer Patients

  12/19/2017

  Feinstein Institute for Medical Research Assistant Professor Catherine Benedict, PhD, has been awarded a two-year, $165,000 grant from the NIH to understand how young women who completed cancer treatment make fertility decisions and plan for future family-building.

• Immunovia Initiates the World's Largest Study of New-Onset Diabetic Patients in a Prospective Pancreas Cancer Study Supported by Swelife

  12/18/2017

  Immunova AB today announced the initiation of PanDIA-1, the world's largest prospective study of the new onset diabetes risk group for pancreatic cancer through a consortium with Lund and Uppsala Universities, Lund University Diabetes Center and Healthcare Region Skåne and Region Uppsala.

• HSS Researchers Receive Grant for Clinical Trial to Improve Outcomes for Rotator Cuff Tears

  12/18/2017

  The $800,000 grant will fund a clinical trial to determine if the use of stem cell therapy can improve outcomes for patients who suffer rotator cuff tears.

• CIRM Grants ViaCyte $1.4M to Create Immune-Evasive Pluripotent Stem Cell Lines

  12/15/2017

  ViaCyte today announced that the CIRM approved a grant of $1.4M to support the initial development of immune-evasive pluripotent stem cell lines.

• Feinstein Institute Uses Bioelectronic Medicine to Treat Lupus

  12/15/2017

  his pilot study will test the effect of an innovative, proprietary device, which emits electrical pulses through the patient's ear five minutes a day for four days.

• Singapore Institutes Collaborate With Samsung Medical Center to Improve Treatment of Liver Cancer

  12/14/2017

  Scientists and doctors from Singapore institutes are collaborating with SMC to develop the world’s first clinically reliable and robust platform that will significantly improve the treatment of hepatocellular carcinoma or liver cancer.

• SIRC Announces Leadership Changes

  12/14/2017

  Executive Director John O. “Jack” Snyder is retiring after more than 24 years with the organization.

• Roswell Park Research Suggests New Strategy for Unleashing Cancer-Fighting Power of P53 Gene Study in Nature Communications Also Adds Weight to Evidence That Antioxidants Can Hamper Chemotherapy

  12/13/2017

  Roswell Park Cancer Institute reports their discovery of a major mechanism by which cells regulate this important and multifunctional tumor suppressor, opening up new avenues for cancer research and treatment.

• ECRI Institute Enhances its Genetic Test Service With New Tool for Decision Makers

  12/13/2017

  The new feature makes it possible for payers and providers to make informed coverage and utilization decisions on genetic tests.

• Baylor Scott & White Research Institute and TGen Poised to Create Early Detection Test for Pancreatic Cancer

  12/12/2017

  The five-year, $5.13 million grant (known as a U01 grant) was awarded by the National Cancer Institute’s Pancreatic Cancer Detection Consortium, an initiative dedicated to bringing researchers together to better understand the disease and to develop and test new molecular and imaging biomarkers.

• SwRI’s ECTO-Lab Quickly, Cost-Effectively Qualifies Catalysts, Emission Control Products

  12/12/2017

  Southwest Research Institute recently opened a new fully automated, multi-fuel burner facility designed to rapidly and cost-effectively age and evaluate exhaust catalyst equipment for a wide range of engines.

• Immunotherapy Drug for Rheumatoid Arthritis Nearly Eliminates Severe Acute Graft-Versus-Host Disease After Hematopoietic Stem Cell Transplant

  12/11/2017

  Abatacept, when added to the standard drug regimen used to prevent GvHD, reduced the occurrence of acute, grade III-IV GvHD from 32 to 3 percent in pediatric and adult patients who underwent mismatched unrelated donor stem cell transplants to treat advanced cancer and other blood disorders.

• Cancer Genetics Advances Understanding of Immune Response and Measurement in Lymphomas by Combining PD-L1 Expression Analysis With RNA Analysis

  12/11/2017

  The results (abstract 1477) were presented on Sunday, December 10, 2017 at the 59th ASH Annual Meeting in Atlanta.

• Fox Chase Cancer Center Researchers Seek Breast Cancer Biomarkers That Indicate Immunotherapy Responsiveness

  12/8/2017

  A small, but significant proportion of patients with invasive breast cancer have at least one of three biomarkers linked to ICB therapy, suggesting a role for such treatment for certain breast cancers, a new study shows.